Abstract
Alzheimer’s disease (AD) is the most tragic and devastating neurologic disorder of the elderly, characterized by personality deterioration and a variety of cognitive disabilities highlighted by memory loss. The earliest symptom of the disease — an inability to remember recent events — eventually advances to a vegetative state in which the victim may be totally unresponsive, incontinent, incapable of self-care and bedfast. The memory deficit progresses to where even friends and family members become unrecognizable. The progression of the disease is highly idiosyncratic, it may take years or only months before it reaches its final stages. Death then follows.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adolfsson, R., Gottfries, C.G., Roos, B.E. and Winblad, B., 1979, Changes in the brain catecholamines in patients with dementia of Alzheimer type, British Journal of Psychiatry, 135: 216–223.
Aghajanian, G.K. and Wang, R.Y., 1978, Physiology’and pharmacology of central serotonergic neurons, in: “Psychopharmacology: A Generation of Progress,” M.A. Lipton, A. DiMascio and K.F. Killam, eds., Raven Press, New York.
Altman, H.J., Crosland, R.D., Jenden, D.J. and Berman, R.F., 1985, Further characterization of the nature of the behavioral and neurochemical effects of lesions to the nucleus basalis of Meynert in the rat, Neurobiology of Aging, 6: 125–130.
Altman, H.J., Normile, H.J. and Ogren, S.O., 1985, Facilitation of discrimination learning in the rat following cytotoxic lesions of the serotonergic nervous system, Society for Neuroscience, Abstract, 11: 874.
Arai, H., Kosaka, K. and Iizuka, R., 1984, Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia, Journal of Neurochemistry, 43: 388–393.
Argentiero, V. and Tavolato, B., 1980, Dopamine and serotonin metabolite levels in the cerebrospinal fluid in Alzheimer’s presenile dementia under phospholipids, Journal of Neurology, 224: 53–58.
Asin, K.E., Wirtshafter, D. and Kent, E.W., 1975, Straight alley acquisition and extinction and open field activity following discrete electrolytic lesions of the mesencephalic raphe nuclei, Behavioral and Neural Biology, 25: 242–256.
Asin, K.E., Wirtshafter, D. and Kent, E.W., 1979, Discrimination learning and reversal following electrolytic median raphe lesions, Society for Neuroscience, Abstract 5: 269.
Asin, K.E. and Fibiger, H.C., 1984, Spontaneous and delayed spatial alternation following damage to specific neuronal elements within the nucleus medianus raphe, Behavioral Brain Research, 13: 241–250.
Asin, K.E., Wirtshafter, D. and Fibiger, H.C., 1985, Electrolytic, but not 5,7-dihyidroxytryptamine, lesions of the nucleus medianus raphe impair acquisition of a radial maze task, Behavioral and Neural Biology, 44: 415–424.
Atack, J.R., Perry, E.K., Bonham, J.R., Perry, R.H., Tomlinson, B.E., Blessed, G. and Fairbairn, A., 1983, Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: Selective loss of the intermediate (10S) form, Neuroscience Letters, 40: 199–205.
Azmitia, E.C. and Segal, M., 1978, An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat, Journal of Comparative Neurology, 179: 641–668.
Bammer, G., 1982, Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: A review and some new results, Neuroscience and Biohehavioral Reviews, 6: 247–296.
Baraban, J.M. and Aghajanian, G.K., 1981, Noradrenergic innervation of serotonergic neurons in the dorsal raphe: Demonstration by electron microscopic autoradiography, Brain Research, 204: 1–11.
Bartus, R.T., Dean, R.L., Beer, B. and Lippa, A.S., 1982, The cholinergie hypothesis of geriatric memory dysfunction, Science, 217: 408–417.
Beller, S.A., Overall, J.E., and Swann, A.C., 1985, Efficacy of oral physostigmine in primary degenerative dementia, Psychopharmacology, 87: 147–151.
Benton, J.S., Bowen, D.M., Allen, S.J., Haan, E.A., Davison, A.N., Neary, D. Murphy, R.P. and Snowden, J.S., 1982, Alzheimer’s disease as a disorder of the isodendritic core, Lancet, 1: 456.
Biegon, A., Kargman, S., Snyder, L. and McEwen, B.S., 1986, Characterization and localization of serotonin receptors in human postmortem brain, Brain Research, 363: 91–98.
Bjorklund, A., Baumgarten, H.G. and Rensch, H.G., 1975, 5,7-dihydroxytryptamine: Improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine, Journal. of Neurochemistry. 24: 833–835.
Blackshear, M.A., Steranka, L.R. and Sanders-Bush, E., 1981, Multiple serotonin receptors: Regional distribution and effect of raphe lesions, European Journal of Pharmacolopg, 76: 325–334.
Blundell, J.E., 1984, Serotonin and appetite, Neuropharmacology, 23: 1537 1551.
Bobillier, P., Petitjean, F., Salvert, D., Ligier, M. and Sequin, S., 1975. Differential projections of the nucleus raphe dorsalis and nucleus raphe centralis as revealed by autoradiography, Brain Research, 85: 205–2104
Bowen, D.M., Smith, C.B., White, P. and Davison, A.N., 1976, Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies, Brain, 99: 459–496.
Bowen, D.M., White, PO., Spillane, J.A., Goodhardt, M.J., Curzon, G., Iwangoff, P., Meier-Ruge, W. and Davison, A.N., 1979, Accelerated aging or selective neuronal loss as an important cause of dementia?, Lancet, is 11–14.
Bowen, D.M., Allen, S.J., Benton, J.S., Goodhardt, M.J., Haan, E.A., Palmer, A.M., Sims, N.R., Smith, C.C.T., Spillane, J.A., Esira, G.K., Neary, D., Snowdon, J.S., Wilcock, G.K. and Davison, A.N., 1983, Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer’s disease, Journal of Neurochemistry, 41: 266–272.
Briley, M., Chopin, P. and Moret, C., 1986, New concepts in Alzheimer’s disease, Neurobiology of Aging, 7: 57–62.
Brinkman, S., Pomara, N., Goodnick, P., Domino, E. and Gerhson, S., 1982, Dose-ranging study of lecithin in the treatment of primary degenerative dementia ( Alzheimer’s disease ), Journal of Clinical Psychopharmacology, 2: 281–285.
Brodie, B. and Shore, P., 1957, A concept for a role of serotonin and norepinephrine as chemical mediators in the brain, Annuals of the New York Academy of Science, 66: 631–642.
Bulat, M. and Zivcovic, N., 1971, Origin of 5-hydroxyindoleacetic acid in the spinal fluid, Science, 173: 738–740.
Candy, J.M., Perry, R.H., Perry, E.K., Irving, D., Blessed, G., Fairbairn, A.F. and Tomlinson, R.L., 1983, Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s diseases, Journal of Neuroscience, 54: 277–289.
Cross, A.J., Crow, T.J., Johnson, J.A., Joseph, M.H., Perry, E.K., Perry, R.H., Blessed, C. and Tomlinson, B., 1983, Monoamine metabolism in senile dementia of Alzheimer type, Journal of Neurological Science, 60: 383 392.
Cross, A.J., Crow, T.J., Johnson, J.A., Perry, E.K., Perry, R.H., Blessed, G. and Tomlinson, B.E., 1984, Studies on neurotransmitter receptor systems in cortex and hippocampus in senile dementia of the Alzheimer-type, Journal of Neurological Science, 64: 109–117.
Cross, A.J., Crow, T.J., Ferrier, I.N. and Johnson, J.A., 1986, The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia, Neurobiology of Aging, 7: 3–7.
Davies, P. and Maloney, A.J.F., 1976, Selective loss of central cholinergic neurons in Alzheimer’s disease, Lancet, ii: 1403.
Davis, K.L., Mohs, R.C., Tinklenberg, J.R., Pfefferbaum, A., Hollister, L.E. and Kopell, B.S., 1978, Physostigmine: Improvement of long-term memory processes in normal humans, Science, 20: 272–274.
Deutsch, J.A. and Rocklin, R., 1967, Amnesia induced by scopolamine and its temporal variations, Nature, 216: 89–90.
Drachman, D.A. and Leavitt., J., 1974, Human memory and the cholinergie system: A relationship to aging, Archives of Neurology, 30: 113–121.
Dundee, J.K.W. and Pandit, S.K., 1972, Anterograde amnesic effects of pethidine, hyoscine and diazepam in adults, British Journal of Pharmacology, 44: 140–144.
Essman, W.B., 1973, Age dependent effects of 5-hydroxytryptamine upon memory consolidation and cerebral protein synthesis, Pharmacology, Biochemistry and Behavior, 1: 7–14.
Euvard, C., Javoy, F., Herbet, A. and Glowinski, J., 1977, Effect of quipazine, a serotonin-like drug, on striatal cholinergie. interneurons, European Journal of Pharmacology, 41:; 281–289.
Fibiger, H.C., 1982, The organization and some projections of cholinergie neurons of the mammalian forebrain, Brain Research Reviews, 4: 327–388.
Fibiger, H.C., Lepiane, F.G. and Phillips, A.G, 1978, Disruption of memory produced by stimulation of the dorsal raphe nucleus: Mediation by serotonin, Brain Research, 1.55:; 380–386.
Flicker, C., Dean, R.L., Watkins, D.L., Fischer, S.K. and Bartus, R.T., 1983, Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat, Pharmacology, Biochemistry and Behavior, 18: 973–991.
Flood, J.F., Smith, G.G. and Cherkin, A., 1983, Memory retention: Potentiation of cholinergic drug combinations in mice, Neurobiology of Aging, 4: 37–43.
Friedman, E., Lerer, B. and Kuster, J., 1983, Loss of cholinergic neurons in rat neocortex produces deficits in passive avoidance learning, Pharmacology Biochemistry and Behavior, 19: 309–312.
Fuxe, K., Ogren, S.O. Agnati, L.F., Jonsson, G. and Gustafsson, J.A., 1978, 5,7-Dihydroxytryptamine as a tool to study the functional role of central 5-hydroxytryptamine neurons, in: “Serotonin Neurotoxins,” J.H. Jacoby and L.D. Lytle, eds., The New York Academy of Sciences, New York.
Garelis, E., Young, S.H. and Lal, S., 1974, Monoamine metabolites in lumbar CSF: The question of their origin in relation to clinical studies, Brain Research, 79: 1–8.
Gottfries, C.G., Cottfries, I. and Roos, B.E., 1969, Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebral spinal fluid of patients with senile dementia, presenile dementia and Parkinsonism, Journal of Neurochemistry, 16: 1341–1345.
Haigler, H.J. and Aghajanian, G.K., 1974, Lysergic acid diethylamide and serotonin: A comparison of effects on serotonergic neurons and neurons receiving serotonergic input, Journal of Pharmacological and Experimental Therapeutics, 188: 688–699.
Hano, J., Vetulani, J. Sansone, M. and Olivero, A., 1981, Changes in action of tricyclic and tetracyclic antidepressants: Desipramine and mianserin, on avoidance behavior in the course of chronic treatment, Psychopharmacology, 73: 265–268.
Hole, K. and Lorens, S.A., 1975, Response to electric shock in rats: Effects of selective midbrain raphe lesions, Pharmacology, Biochemistry, and Behavior, 3: 95–102.
Hole, K., Fuxe, K. and Jonsson, G., 1976, Behavioral effects of 5,7dihydroxytryptamine lesions of ascending 5-hydroxytryptamine pathways, Brain Research, 107: 385–399.
Ishii, I., 1966, Distribution of Alzheimer’s neurofibrillary changes in the brain stem and hypothalamus of senile dementia, Archives of Neuropathology, 6: 181–187.
Jacobs, B.L., Wise, W.D. and Taylor, K.M., 1974, Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats, Brain Research, 79–353–361.
Janssen, P.A.J., 1981, The pharmacology of specific, pure and potent serotonin 5-HT2 or S2-antagonists, Eight International Congress of Pharmacology, Tokyo ( Japan ), July 19–24.
Johnston, M.V., McKinney, M. and Coyle, J.T., 1979, Evidence for a cholinergic projection to the neocortex from neurons in basal forebrain, Proceedings of the National Academy of Science, 76: 5392–5396.
Jouvet, M., 1969, Biogenic amines and the states of sleep, Science, 163: 32–34.
Koe, B.K. and Weissman, A., 1966, p-Chlorophenylalanine: A specific depletor of brain serotonin, Journal of Pharmacological and Experimental Therapeutics, 154: 499–516.
Kruglikov, R.I., 1982, On the interaction of neurotransmitters in processes of learning and memory. in: “Neuronal Plasticity and Memory Formation,” C.A. Marsan and H. Matthies, eds., Raven Press, New York.
Leysen, J.E., Awouters, F., Kennis,L., Laduron, P.M., Vandenberk, J. and Janssen, P.A.J., 1981, Receptor binding profile of R-41,468, a novel antagonist at 5-HT2 receptors, Life Sciences, 28: 1015–1022.
LoConte, G., Bartolini, L., Casamenti, F., Marconcini-Pepeu, I. and Pepeu, G., 1982, Lesions of cholinergic forebrain nuclei: Changes in avoidance behavior and scopolamine actions, Pharmacology, Biochemistry and Behavior, 17: 933–937.
Longo, V.G., 1966, Behavioral and electroencephalographic effects of atropine and related compounds, Pharmacological Reviews, 18: 965–966
Lorens, S.A., 1978, Some behavioral effects of serotonin depletion depend on method: A comparison of 5,7-dihydroxytryptamine, p-chlorophenylalanine, p-chloroamphetamine, and electrolytic raphe lesions, in: “Serotonin Neurotoxins, J.H. Jacoby and L.D. Lytle, eds., New York Academy of Sciences, New York.
Lorens, S.A. and Guldberg, H.C., 1974, Regional 5-hydroxytryptamine following selective midbrain raphe lesions in the rat, Brain research, 78: 45–56.
Lorens, S.A. and Yunger, L.M., 1974, Morphine analgesia, two-way avoidance, and consummatory behavior following lesions in the midbrain raphe nuclei in the rat, Pharmacology, Biochemistry and Behavior, 2: 215–221.
Lorens, S.A., Guldberg, H.C., Hole, K., Kohler, C. and Srebro, B., 1976, Activity, avoidance learning and regional 5-hydroxytryptamine following intrabrain stem 5,7-dihydroxytryptamine and electrolytic midbrain raphe lesions in the rat, Brain Research, 108: 97–113. 4
Mann, D.M.A. and Yates, P.O., 1983, Serotonin nerve cells in Alzheimer’s disease, Journal of Neurological and Neurosurgical Psychiatry, 46: 96.
Montanaro, N., Dall’Olio, R. and Gandolfi, 0., 1981, Reduction of ECSinduced retrograde amnesia of passive avoidance conditioning after 5,7dihydroxytryptamine median raphe nucleus lesion in the rat, Neuro-psychobiology, 7: 56–67.
Normale, H.J. and Altman, H.J., 1985, The effects of serotonergic receptor blockade on learning and memory in mice, Society for Neuroscience, Abstract, 11: 875.
Normile, H.J. and Altman, H.J., 1986, Evidence for a possible interaction between noradrenergic and serotonergic neurotransmission in the retrieval of a previously learned aversive habit in mice, Psychopharmacology, 92: 388–392.
Ochi, J. and Shimizu, K., 1978, Occurrence of dopamine-containing neurons in the midbrain raphe nuclei of the rat, Neuroscience, 8: 317–320.
Ogren, S.O., Kohler, C., Ross, S.B. and Srebro, B., 1976, 5-hydroxytryptamine depletion and avoidance acquisition in the rat. Antagonism of the long-term effects of p-chloroamphetami.ne with a selective inhibitor or 5-hydroxytryptamine uptake, Neuroscience Letters, 3: 341–347.
Ogren, S.O., Fuxe, K., Archer, T., Hall, H., Holm, A.C. and Kohler, C., 1981, Studies on the role of central 5-HT neurons in avoidance learning: A behavioral and biochemical analysis. in: “Serotonin: Current Aspects of Neurochemistry and Function,’ B. Gabay, S. Issidorides, M.R., Alivisatos, S.G.A., eds., Plenum Press, New York.
Ogren, S.O. and Johansson, C., 1985, Separation of the associative and non-associative effects of brain serotonin released by p-chloroamphetamine: Dissociable serotonergic involvement in avoidance learning, pain and motor function, Psychopharmacology, 86: 12–26.
Ogren, S.O., Altman, H.J. and Bartfai, T., 1987, Alaproclate potentiation of muscarinic agonist evoked tremor, salivation and enhanced recall, in: Synaptic Transmitters and Receptors,“ S. Tucek., ed., John Wiley and Sons, Chichester, U.K. (In press).
O’Hearn, E. and Molliver, M.E., 1984, Organization of raphe-cortical projections in the rat: A quantitative retrograde study, Brain Research Bulletin, 13: 7i09–726.
Palmer, A.M., Sims, N.S., Bowen, D.M., Neary, D., Palo, J., Wikstrom, J. and Davison, A.N., 1984, Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histology verified Alzheimer’s dementia, Journal of Neurological and Neurosurgical Psychiatry, 47: 481–484.
Peroutka, S.J. and Snyder, S.H., 1979, Multiple serotonin receptors: Differential binding of 3H-serotonin, 3H-lysergic acid diethylamide and 3H-spiroperidol, Molecular Pharmacology, 16: 687–699.
Peroutka, S.J., Lebovitz, R.M. and Snyder, S.H., 1981, Two distinct central serotonin receptors with different physiologic functions, Science, 212: 827–829.
Perry, E.K., Perry, R.H., Blessed, G. and Tomlinson, B.E., 1977, Necropsy evidence of central cholinergic deficits in senile dementia, Lancet, is 189.
Perry, E.K., Tomlinson, B.E., Blessed, G. Bergmann, K., Gibson, P.H. and Perry R.H., 1978, Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia, British Medical Journal, 2: 1457–1459.
Pope, A., Hess, H.H. and Levin, E, 1965,. Neurochemical pathology of the cerebral cortex in presenile dementias, Transactions of the American Neurological Association, 89: 15–16.
Quirion, R., Richard, J. and Dam, T.V., 1985, Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex, Brain Research, 333: 345–349.
Reynolds, G.P., Arnold, L., Rossor, M.N., Iversen, L.L., Mountjoy, C.Q. and Roth, M., 1984, Reduced binding of (3H)ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type, Neuroscience Letters, 44: 47–51.
Roberts, M.H.T., 1984, 5-Hydroxytryptamine and antinociception, Neuro-pharmacology, 23: 1529–1536.
Samanin, R., Quattrone, A., Prei, G., Ladinski, H. and Consolo, S., 1978, Evidence for an interaction between serotonergic and cholinergic neurons in the corpus striatum and hippocampus of the rat brain, Brain Research, 151: 73–82
Sitaram, N., Weingartner, H. and Gillin, K.C., 1978, Human serial learning enhancement with arecoline and impairment with scopolamine, Science, 201: 274–276.
Srebro, B. and Lorens, S.A., 1975, Behavioral effects of selective midbrain raphe lesions in the rat, Brain Research, 89: 303–325.
Srebro, B. Jellestad, F. and Lorens, S.A., 1975, Activity, avoidance behavior, and spatial reversal learning after midbrain raphe lesions, Experimental Brain Research, 23: 193.
Steinbusch, H.W.M., 1984, Serotonin-immunoreactive neurons and their projection in the CNS, in: “Handbook of Chemical Neuroanatomy,” A. Bjorklund, T. Hokfelt and M.J. Kuhar, eds., Elsevier, New York.
Stevens, D.A., Flechter, L.D. and Resnick, 0., 1969, The effects of p-chlorophenylalanine, a depletor of brain serotonin, on behavior: Retardation of passive avoidance learning, Life Science, 8: 379–385.
Summers, W.K., Viesselman, J.0., Marsh, G.M. and Candelora, K., 1981, Use of THA in treatment of Alzheimer-like dementia: Pilot study in twelve patients, Biological Psychiatry, 16: 145–153.
Valzelli, L. and Pawlowski, L., 1979, Effect of p-chlorophenylalanine on avoidance learning of two differentially housed mouse strains, Neuro-psychobiology, 5: 121–128.
Vanderwolf, C.H. and Baker, G.B., 1986, Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior, Brain Research, 374: 342–356.
Volicer, L., Langlais, P.J., Matson, W.R., Mark, K.A. and Gamache, P.H., 1985, Serotonergic system in dementia of the Alzheimer type, Archives of Neurology, 42: 1158–1161.
Wetzel, W., Getsova, V.M., Jork, R. and Matthies, H., 1980, Effect of serotonin on Y-maze retention and hippocampal protein synthesis in rats. Pharmacology, Biochemistry and Behavior, 12: 319–322.
Whitehouse, P.J., Price, D.L., Clark, A.W., Coyle, J.T. and DeLong, M.R., 1981, Alzheimer’s disease: Evidence for a selective loss of cholinergic neurons in the nucleus basalis, Annals of Neurology, 10: 122–126.
Winblad, B., Adolfsson, R., Carlsson, A. and Gottfries, C.G., 1982, Biogenic amines in brains of patients with Alzheimer’s disease. in: “Alzheimer’s Disease: A Report of Progress. Vol. 19, Aging,” S. Corkin, K.L. Davis, J.H. Growdon, E. Usdin and R.J. Wurtman, eds., Raven Press, New York.
Wirtshafter, D. and Asin, K.E., 1983, Impaired radial maze performance in rats with electrolytic median raphe lesions, Experimental Neurology, 79: 412–412.
Wooley, D.W. and Van der Hoeven, T., 1963, Alteration in learning ability caused by changes in cerebral serotonin and catecholamines, Science, 139: 610–611.
Yamamoto, T., Hirano, A., 1985, Nucleus raphe dorsalis in Alzheimer’s disease: Neurofibrillary tangles and loss of large neurons, Annals of Neurology, 17: 573–577.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media New York
About this chapter
Cite this chapter
Normile, H.J., Altman, H.J. (1987). Serotonin, Alzheimer’s Disease and Learning and Memory in Animals. In: Altman, H.J. (eds) Alzheimer’s Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6414-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6414-0_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-6416-4
Online ISBN: 978-1-4615-6414-0
eBook Packages: Springer Book Archive